tradingkey.logo

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer

ReutersFeb 3, 2026 1:11 PM

- GSK plc GSK.L:

  • GSK - QUEBEC TO REIMBURSE JEMPERLI PLUS CHEMOTHERAPY VIA RAMQ FOR TREATMENT OF PATIENTS WITH PRIMARY ADVANCED/FIRST RECURRENT ENDOMETRIAL CANCER

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI